Integrative Phosphoproteomics Links IL-23R Signaling with Metabolic Adaptation in Lymphocytes

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lochmatter, Corinne ^a,b   Fischer, Roman ^a,b   Charles, Philip D ^b   Yu, Zhanru ^b   Powrie, Fiona ^a   Kessler, Benedikt M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; IL23R PROTEIN, HUMAN; INTERLEUKIN 23; INTERLEUKIN RECEPTOR; MEMBRANE PROTEIN; PHOSPHOPEPTIDE; PHOSPHOPROTEIN; STAT3 PROTEIN; THYROID HORMONE; THYROID HORMONE-BINDING PROTEINS;

ACTIVE TRANSPORT; ADAPTATION; BIOLOGICAL MODEL; DRUG EFFECTS; ENERGY METABOLISM; GLYCOLYSIS; HUMAN; LYMPHOCYTE; METABOLISM; PHOSPHORYLATION; PROCEDURES; PROTEIN DATABASE; PROTEOMICS; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAPTATION, BIOLOGICAL; CARRIER PROTEINS; DATABASES, PROTEIN; ENERGY METABOLISM; GLYCOLYSIS; HUMANS; INTERLEUKIN-23; LYMPHOCYTES; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PHOSPHOPEPTIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEOMICS; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; THYROID HORMONES;

EID: 84964211524     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24491     Document Type: Article

References (62)

1. Liu, Y. & Chance, M. R. Integrating phosphoproteomics in systems biology. Computational and structural biotechnology journal 10, 90-97, doi: 10.1016/j.csbj.2014.07.003 (2014).
2. Ozlu, N. et al. Phosphoproteomics. Wiley interdisciplinary reviews. Systems biology and medicine 2, 255-276, doi: 10.1002/wsbm.41 (2010).
3. Macek, B., Mann, M. & Olsen, J. V. Global and site-specific quantitative phosphoproteomics: principles and applications. Annual review of pharmacology and toxicology 49, 199-221, doi: 10.1146/annurev.pharmtox.011008.145606 (2009).
4. Ruprecht, B. et al. Comprehensive and reproducible phosphopeptide enrichment using iron immobilized metal ion affinity chromatography (Fe-IMAC) columns. Molecular & cellular proteomics: MCP 14, 205-215, doi: 10.1074/mcp.M114.043109 (2015).
5. Posewitz, M. C. & Tempst, P. Immobilized gallium(III) affinity chromatography of phosphopeptides. Analytical chemistry 71, 2883-2892 (1999).
6. Neville, D. C. et al. Evidence for phosphorylation of serine 753 in CFTR using a novel metal-ion affinity resin and matrix-assisted laser desorption mass spectrometry. Protein science: a publication of the Protein Society 6, 2436-2445, doi: 10.1002/pro.5560061117 (1997).
7. Pinkse, M. W., Uitto, P. M., Hilhorst, M. J., Ooms, B. & Heck, A. J. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Analytical chemistry 76, 3935-3943, doi: 10.1021/ac0498617 (2004).
8. Sano, A. & Nakamura, H. Titania as a chemo-affinity support for the column-switching HPLC analysis of phosphopeptides: application to the characterization of phosphorylation sites in proteins by combination with protease digestion and electrospray ionization mass spectrometry. Analytical sciences: the international journal of the Japan Society for Analytical Chemistry 20, 861-864 (2004).
9. Larsen, M. R., Thingholm, T. E., Jensen, O. N., Roepstorff, P. & Jorgensen, T. J. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Molecular & cellular proteomics:MCP 4, 873-886, doi: 10.1074/mcp.T500007-MCP200 (2005).
10. Zhou, H. et al. Toward a comprehensive characterization of a human cancer cell phosphoproteome. Journal of proteome research 12, 260-271, doi: 10.1021/pr300630k (2013).
11. Engholm-Keller, K. et al. TiSH-a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC. Journal of proteomics 75, 5749-5761, doi: 10.1016/j.jprot.2012.08.007 (2012).
12. McNulty, D. E. & Annan, R. S. Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Molecular & cellular proteomics: MCP 7, 971-980, doi: 10.1074/mcp.M700543-MCP200 (2008).
13. Navarro, M. N., Goebel, J., Hukelmann, J. L. & Cantrell, D. A. Quantitative phosphoproteomics of cytotoxic T cells to reveal protein kinase d 2 regulated networks. Molecular & cellular proteomics: MCP 13, 3544-3557, doi: 10.1074/mcp.M113.037242 (2014).
14. Navarro, M. N., Feijoo-Carnero, C., Arandilla, A. G., Trost, M. & Cantrell, D. A. Protein kinase D2 is a digital amplifier of T cell receptor-stimulated diacylglycerol signaling in naive CD8(+) T cells. Science signaling 7, ra99, doi: 10.1126/scisignal.2005477 (2014).
15. Salek, M. et al. Quantitative phosphoproteome analysis unveils LAT as a modulator of CD3zeta and ZAP-70 tyrosine phosphorylation. Plos one 8, e77423, doi: 10.1371/journal.pone.0077423 (2013).
16. Wu, C. J., Chen, Y. W., Tai, J. H. & Chen, S. H. Quantitative phosphoproteomics studies using stable isotope dimethyl labeling coupled with IMAC-HILIC-nanoLC-MS/MS for estrogen-induced transcriptional regulation. Journal of proteome research 10, 1088-1097, doi: 10.1021/pr100864b (2011).
17. Ruperez, P., Gago-Martinez, A., Burlingame, A. L. & Oses-Prieto, J. A. Quantitative phosphoproteomic analysis reveals a role for serine and threonine kinases in the cytoskeletal reorganization in early T cell receptor activation in human primary T cells. Molecular & cellular proteomics: MCP 11, 171-186, doi: 10.1074/mcp.M112.017863 (2012).
18. Trost, M., Bridon, G., Desjardins, M. & Thibault, P. Subcellular phosphoproteomics. Mass spectrometry reviews 29, 962-990, doi: 10.1002/mas.20297 (2010).
19. Osinalde, N. et al. Simultaneous dissection and comparison of IL-2 and IL-15 signaling pathways by global quantitative phosphoproteomics. Proteomics 15, 520-531, doi: 10.1002/pmic.201400194 (2015).
20. Storvold, G. L. et al. Quantitative profiling of tyrosine phosphorylation revealed changes in the activity of the T cell receptor signaling pathway upon cisplatin-induced apoptosis. Journal of proteomics 91, 344-357, doi: 10.1016/j.jprot.2013.07.019 (2013).
21. Osinalde, N. et al. Interleukin-2 signaling pathway analysis by quantitative phosphoproteomics. Journal of proteomics 75, 177-191, doi: 10.1016/j.jprot.2011.06.007 (2011).
22. de Wet, B., Zech, T., Salek, M., Acuto, O. & Harder, T. Proteomic characterization of plasma membrane-proximal T cell activation responses. The Journal of biological chemistry 286, 4072-4080, doi: 10.1074/jbc.M110.165415 (2011).
23. Brockmeyer, C. et al. T cell receptor (TCR)-induced tyrosine phosphorylation dynamics identifies THEMIS as a new TCR signalosome component. The Journal of biological chemistry 286, 7535-7547, doi: 10.1074/jbc.M110.201236 (2011).
24. Hue, S. et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. The Journal of experimental medicine 203, 2473-2483, doi: 10.1084/jem.20061099 (2006).
25. Frucht, D. M. IL-23: a cytokine that acts on memory T cells. Science's STKE: signal transduction knowledge environment 2002, pe1, doi: 10.1126/stke.2002.114.pe1 (2002).
26. Geremia, A. et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. The Journal of experimental medicine 208, 1127-1133, doi: 10.1084/jem.20101712 (2011).
27. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375, doi: 10.1038/nature08949 (2010).
28. Ahern, P. P. et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity 33, 279-288, doi: 10.1016/j.immuni.2010.08.010 (2010).
29. Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol 14, 585-600, doi: 10.1038/nri3707 (2014).
30. Polgar, N. et al. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease. Int J Immunogenet 39, 247-252, doi: 10.1111/j.1744-313X.2012.01084.x (2012).
31. Yang, L. et al. Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3. J Dermatol Sci, doi: 10.1016/j.jdermsci.2015.11.007 (2015).
32. Wessel, D. & Flugge, U. I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Analytical biochemistry 138, 141-143 (1984).
33. Boersema, P. J., Raijmakers, R., Lemeer, S., Mohammed, S. & Heck, A. J. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nature protocols 4, 484-494, doi: 10.1038/nprot.2009.21 (2009).
34. Hammond, D. et al. Melanoma-associated mutations in protein phosphatase 6 cause chromosome instability and DNA damage owing to dysregulated Aurora-A. Journal of cell science 126, 3429-3440, doi: 10.1242/jcs.128397 (2013).
35. Jensen, S. S. & Larsen, M. R. Evaluation of the impact of some experimental procedures on different phosphopeptide enrichment techniques. Rapid Commun Mass Spectrom 21, 3635-3645, doi: 10.1002/rcm.3254 (2007).
36. Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nature protocols 2, 1896-1906, doi: 10.1038/nprot.2007.261 (2007).
37. Geiger, T., Wehner, A., Schaab, C., Cox, J. & Mann, M. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Molecular & cellular proteomics: MCP 11, M111 014050, doi: 10.1074/mcp.M111.014050 (2012).
38. Mehrotra, P. T., Grant, A. J. & Siegel, J. P. Synergistic effects of IL-7 and IL-12 on human T cell activation. Journal of immunology 154, 5093-5102 (1995).
39. Steen, H., Jebanathirajah, J. A., Rush, J., Morrice, N. & Kirschner, M. W. Phosphorylation analysis by mass spectrometry: myths, facts, and the consequences for qualitative and quantitative measurements. Molecular & cellular proteomics: MCP 5, 172-181, doi: 10.1074/mcp.M500135-MCP200 (2006).
40. Gao, X., Wang, H., Yang, J. J., Liu, X. & Liu, Z. R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Molecular cell 45, 598-609, doi: 10.1016/j.molcel.2012.01.001 (2012).
41. Keilhauer, E. C., Hein, M. Y. & Mann, M. Accurate protein complex retrieval by affinity enrichment mass spectrometry (AE-MS) rather than affinity purification mass spectrometry (AP-MS). Molecular & cellular proteomics: MCP 14, 120-135, doi: 10.1074/mcp.M114.041012 (2015).
42. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteomewide protein quantification. Nat Biotechnol 26, 1367-1372, doi: 10.1038/nbt.1511 (2008).
43. Herhaus, L. et al. Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization. Science signaling 8, ra35, doi: 10.1126/scisignal.aaa0441 (2015).
44. Mihlan, S. et al. Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions. Oncogene 32, 2107-2113, doi: 10.1038/onc.2012.216 (2013).
45. Handschick, K. et al. Cyclin-dependent kinase 6 is a chromatin-bound cofactor for NF-kappaB-dependent gene expression. Molecular cell 53, 193-208, doi: 10.1016/j.molcel.2013.12.002 (2014).
46. Gringhuis, S. I., Kaptein, T. M., Wevers, B. A., Mesman, A. W. & Geijtenbeek, T. B. Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKepsilon- and CYLD-dependent Bcl3 activation. Nature communications 5, 3898, doi: 10.1038/ncomms4898 (2014).
47. Buss, H. et al. Cyclin-dependent kinase 6 phosphorylates NF-kappaB P65 at serine 536 and contributes to the regulation of inflammatory gene expression. Plos one 7, e51847, doi: 10.1371/journal.pone.0051847 (2012).
48. Kohrt, D. M., Crary, J. I., Gocheva, V., Hinds, P. W. & Grossel, M. J. Distinct subcellular distribution of cyclin dependent kinase 6. Cell cycle 8, 2837-2843 (2009).
49. Nielsen, M., Svejgaard, A., Skov, S. & Odum, N. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur J Immunol 24, 3082-3086, doi: 10.1002/eji.1830241225 (1994).
50. Liu, L., McBride, K. M. & Reich, N. C. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importinalpha3. Proceedings of the National Academy of Sciences of the United States of America 102, 8150-8155, doi: 10.1073/pnas.0501643102 (2005).
51. Blumert, C. et al. Analysis of the STAT3 interactome using in-situ biotinylation and SILAC. Journal of proteomics 94, 370-386, doi: 10.1016/j.jprot.2013.08.021 (2013).
52. Demaria, M. & Poli, V. PKM2, STAT3 and HIF-1alpha: The Warburg's vicious circle. Jak-Stat 1, 194-196, doi: 10.4161/jkst.20662 (2012).
53. Yang, W. et al. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nature cell biology 14, 1295-1304, doi: 10.1038/ncb2629 (2012).
54. Wang, T., Marquardt, C. & Foker, J. Aerobic glycolysis during lymphocyte proliferation. Nature 261, 702-705 (1976).
55. Jacobs, S. R. et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. Journal of immunology 180, 4476-4486 (2008).
56. Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769-777 (2002).
57. Shi, L. Z. et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. The Journal of experimental medicine 208, 1367-1376, doi: 10.1084/jem.20110278 (2011).
58. Peter, K., Rehli, M., Singer, K., Renner-Sattler, K. & Kreutz, M. Lactic acid delays the inflammatory response of human monocytes. Biochem Biophys Res Commun 457, 412-418, doi: 10.1016/j.bbrc.2015.01.005 (2015).
59. Spadaro, A. et al. HIF1a is Induced by the Pro-Inflammatory IL-23 in Dendritic Cells but Not Macrophages. J of Surgical Research 186, 688 (2014).
60. Luo, W. et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732-744, doi: 10.1016/j.cell.2011.03.054 (2011).
61. Barbi, J., Pardoll, D. & Pan, F. Metabolic control of the Treg/Th17 axis. Immunol Rev 252, 52-77, doi: 10.1111/imr.12029 (2013).
62. Lo, R. K., Cheung, H. & Wong, Y. H. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism. The Journal of biological chemistry 278, 52154-52165, doi: 10.1074/jbc.M307299200 (2003).